Maria Carolina Sisco, Marlei Gomes da Silva, Luciana Distasio de Carvalho, Carlos Eduardo Dias Campos, Paulo Cesar De Souza Caldas, Beatriz Lopez, Claudia Argüelles, Ana Carolina Carvalho, Jacobus de Waard, Philip Suffys, Rafael Silva Duarte
Purpose: Mycobacterium bovis Bacillus Calmette-Guérin (BCG) is the only vaccine licensed against tuberculosis. Despite the protection offered by the vaccine, in some circumstances children and immunocompromised individuals can develop associated infections, known as BCGitis. Drug susceptibility patterns of BCG clinical strains have rarely been described. We aimed to describe the susceptibility pattern of BCG clinical strains isolated in two different countries. Methods: We performed culture-based drug susceptibility testing of thirty one BCG strains isolated from patients in Brazil (n=5, 16%) and Argentina (n=26, 84%) using the broth micro-dilution method (phenotypic method)...
2021: Infection and Drug Resistance